Refine by
Industries served
- Medical / Health Care
- Agriculture
- Monitoring and Testing
- Air and Climate
- Water and Wastewater
- Environmental
- Health and Safety
- Manufacturing, Other
- Food and Beverage
- Chemical & Pharmaceuticals
- Real Estate
- Oil, Gas & Refineries
- Construction & Construction Materials
- Mining
- Automobile & Ground Transport
- Defense
- Domestic
- Aerospace & Air Transport
- Forestry & Wood
- Waste and Recycling
- Travel & Leisure
- Soil and Groundwater
- University / Academia / Research
- Government
- Energy
Influenza Virus Suppliers Near Taiwan
36 companies found
based inSouth Melbourne, AUSTRALIA
BioDiem is an Australian biopharmaceutical company that is focused on developing and commercialising vaccines and infectious disease therapies. Our business model is to generate income from partnerships including with other vaccine and infectious ...
A core technology advantage: Live Attenuated Influenza Virus (LAIV) vaccine. BioDiem’s lead asset is the Live Attenuated Influenza Virus (LAIV) vaccine technology. Our LAIV ...
based inLa Jolla, CALIFORNIA (USA)
Liferiver is a leading PCR-based molecular diagnostics solution provider, developing, manufacturing & marketing real time PCR diagnostic kits as well as instruments. We offer over 400 testing kits covering most infectious diseases, genetic diseases, ...
LightCycler 1.0 (Internal control can't be used for this system). LightCycler 2.0. PE5700, MJ-Opticon & other single color systems. ABI7000, ABI7300, ABI7500, ABI7900, ABI StepOne, StepOne plus, MJ-Opticon2, MJ-chromo4, MX3000P, MX3005P, Smart ...
based inVienna, AUSTRIA
Nuvonis is a biotech company based in Vienna, Austria, providing innovative Cell Banks and technical support for vaccine development. The Nuvonis team is highly experienced in all aspects of vaccine production, both in small biotech companies up to ...
The generation of high titer vaccines with acceptable purity is a challenging task, both regarding upstream and downstream steps. Upstream development uses well established technologies such as bioreactors (e.g., single use) or high-cell density ...
based inNorth Ryde, AUSTRALIA
Biotron Limited (Biotron) is a clinical stage publicly listed Australian Biotechnology Company based in Sydney, Australia. The company is developing and commercialising a novel small molecule approach that has the potential to treat a number of ...
Biotron is developing novel small molecule antiviral therapeutics targeting a range of viruses including Hepatitis C virus (HCV) and ...
based inCuarte de Huerva (Zaragoza), SPAIN
OPERON was established 1973 as a private R&D laboratory in the field of immunochemistry. Initially, the target of the company was to satisfy the needs of the Spanish market. Three years later, the strategy changed focusing on the international ...
One-step immunochromatographic test combining two strips for the qualitative and differential detection of Respiratory Syncytial Virus (RSV) and respiratory Adenovirus, from respiratory samples such us nasopharyngeal swabs, washes and aspirates. ...
based inSuwon-si, SOUTH KOREA
We are continually challenging ourselves to become a leading company specialized in in-vitro diagnostics and dedicated to creating value for human health innovation. We are the pioneers of diagnostic kit and technology, specializing in the area of ...
Influenza, one of the most common infectious diseases, is a highly contagious airborne disease that occurs in seasonal epidemics. There are three types of flu viruses: A, B, and C. Type A and B that cause the annual influenza epidemics in the ...
based inGaithersburg, MARYLAND (USA)
Altimmune is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company’s lead product candidate, pemvidutide, is a GLP-1/glucagon dual ...
A recombinant intranasal vaccine that is being developed for both seasonal and pandemic use. NasoVAX can activate the humoral, mucosal and cellular immune arms in unison for a more comprehensive immune response. The data from our Phase 2a trial with ...
based inTübingen, GERMANY
Founded in 2015, Atriva Therapeutics is a biopharmaceutical company specifically pioneering the development of host-targeting antiviral therapies set up by a team of leading scientists in viral research and seasoned industry experts. The company ...
The company’s lead drug candidate is the MEK inhibitor zapnometinib. The small molecule, which can be administered orally (tablet), is under advanced clinical development in two severe respiratory viral diseases: COVID-19 and influenza, two ...
based inAhrensburg, GERMANY
ulti med Products (Deutschland) GmbH specialises in the development, manufacture as well as worldwide export of high-quality In-vitro diagnostics and drug tests. The high quality standards applicable to our products and our quality management system ...
The ulti med Influenza A+B Antigen Test is a rapid chromatographic immunoassay for the qualitative detection of Influenza A and B antigens in nasopharyngeal swab specimens. It is intended to aid in the rapid differential diagnosis of influenza A and ...
based inWoodland, CALIFORNIA (USA)
Hygieia Biological Laboratories is a Woodland, California based biotechnology company engaged in the research, development and manufacturing of innovative veterinary and human vaccines and pharmaceuticals. We have particular expertise in vaccines ...
Preventative health including vaccination is a key focus of good animal management. Hygieia offers inactivated autogenous bacterins and vaccines which are custom manufactured from disease agents specifically found at an individual ranch, zoo, or ...
based inBusan, SOUTH KOREA
We, huonsmedicare, provide medicine and medical supplies such as disinfectant, blood dialysis and coolyrium etc, At the beginning of our business, nation's first Hemoclean based on peracetic acid was made by our own research staffs and we were ...
Purpose of use: sterilization of small spaces. Size (W*D*H): 500*20*495mm. weight: 19.5kg. voltage: 220V (60Hz) Sterilization of small spaces: Up to 150? ...
based inSnailwell, UNITED KINGDOM
Tristel is a manufacturer of infection control, contamination control and hygiene products. It has four principal activities: Medical Instrument Disinfection under the Tristel brand. Hospital Surface Disinfection under the Cache brand. Cleanroom, ...
based inMaidenhead, UNITED KINGDOM
As a global leader in influenza protection, CSL Seqirus has one of the broadest influenza vaccine portfolios in the world. In the Asia Pacific region we also provide access to a wide range of vaccines and specialty medicines that meet unique, local ...
As a global leader in influenza protection, Seqirus has one of the broadest influenza vaccine portfolios in the world. In the Asia Pacific region we also provide access to a wide range of vaccines and specialty medicines that meet unique, local ...
based inAntwerp, BELGIUM
At Innovad we combine people’s long time experiences in the field of animal feed and water additives with an innovative approach and dedication to animal well-being and a healthy environment. At the same time we secure cost effectiveness for the ...
Streptococcus suis (S. suis) was first reported in 1954 after outbreaks of meningitis, septicemia, and purulent arthritis among piglets (Hughes et al., 2009). Nowadays, it can still be seen as a major porcine pathogen. Infection with S. suis is one ...
based inBurnaby, BRITISH COLUMBIA (CANADA)
Fusion Genomics is a Vancouver-based company that is advancing molecular diagnostics by developing identification tests for pathogens using proprietary technologies in combination with Next Generation Sequencing. Our ONETest products, in combination ...
The ONETest Influenza EnviroScreen assay was developed for sensitive and scalable detection of influenza viruses in environmental samples. The assay is highly optimized for soil and wetland sediment samples from temperate regions, and can ...
based inMadison, WISCONSIN (USA)
FluGen, Inc. is developing a more effective vaccine in the fight against influenza and respiratory disease. The M2SR Vaccine Platform has the potential to revolutionize the $5 billion annual influenza market, with a clinically-tested vaccine ...
The M2 Deleted Single Replication Live Virus Vaccine (M2SR) offers a potentially differentiating clinical value proposition. FluGen’s flu vaccine candidate works differently, stimulating mucosal, humoral, and cellular immunity, and offering ...
based inGeumcheon-gu, SOUTH KOREA
Since KogeneBiotech was founded in 2000, and our company has earned a reputation for innovation in Molecular Diagnostics. Our main business units are the production of Real-time PCR/conventional assay based on the active R&D works and testing ...
PowerChek SARS-CoV-2, Influenza A&B, RSV Multiplex Real-time PCR Kit II provides the fast and accurate testing solution for of nucleic acid from SARS-CoV-2 that causes Coronavirus Disease 2019 (COVID-19), ...
based inGuangzhou, CHINA
Guangzhou Wondfo Biotech Co., Ltd., headquartered in Guangzhou science city, has been focusing on the R&D, production, sales and service of point-of-care testing (POCT) products and providing customers with professional rapid diagnosis and chronic ...
based inReeuwijk, NETHERLANDS
BioChek provides an accurate, reliable and easy-to-use animal health monitoring system for the Poultry and Swine industry, and associated diagnostic solutions for Food Safety testing. This system consists of a broad range of ELISA and PCR test kits, ...
based inShirley, NEW YORK (USA)
CD BioSciences is a leading customer-focused biotechnology company founded in New York. Virus-like particles (VLPs) constructed on plant-based platforms can be produced on a large scale as plants can be grown cheaply and efficiently without the need ...
Virus-like particles (VLPs) are nanoscale structures composed of assembled viral proteins that lack viral genetic material and are therefore not infectious. CD BioSciencesoffers VLPlantTM, a plant-based recombinant expression system for constructing ...